Dr Kannan Vishwanatth promoted Dr Ashleys Limited to expand pharmaceutical warehousing at Riga, Latvia

Logo EIN Presswire
EIN Presswire

Prof. Dr Kannan Vishwanatth, Managing Director, Dr Ashley's Limited

Prof. Dr. Kannan Vishwanatth, Academic Researcher at the Rigas, Lativia

Chemical Engineer Dr Kannan Vishwanatth

Dr Ashleys Limited defines new markets by continually extending the frontiers of research and development in its chosen field of business.

Dr Ashleys Limited based out of Hong Kong is a key player in Pharmaceutical Medical & Surgical Products with presence of more than 75 plus countries including complex markets in Africa, UAE & Europe”
— Prof. Dr Lammam Vishwanatth
CALIFORNIA, UNITED STATES OF AMERICA, January 24, 2023 /EINPresswire.com/ -- Dr Ashleys Limited is also zeroing on collaborating with major pharmaceutical manufacturing companies & herbal manufacturers for catering to the growing number of distributors & franchises in Europe.

Dr Ashleys Limiteds continuous & strategic expansion in Europe, which included new geographic branch openings in several key countries in Europe like France, Germany, Finland, Portugal, Switzerland, Belgium, Italy, Spain, Denmark, Sweden, Greece, Netherlands, and Norway etc. allowed Dr Ashleys Limited to stay in front of customer requirements throughout 2022 and mitigate challenges the region has faced, ensuring the continuous flow of goods. With the increased number of clients & geographic expansion coupled with unique range of pharmaceutical & herbal products, the company needed a strong automated warehouse to house raw materials and to package medications. This installation had to have enough storage capacity to cope with increased production, whose operations have been fully-automated to ensure the maximum safety of goods and achieve high throughput. Dr Ashleys Limited has already developed a state of the art ware housing facilities in Hong Kong.

Dr Ashleys Limited based out of Hong Kong is a key player in Pharmaceutical Medical & Surgical Products with presence of more than 75 plus countries including complex markets such as Africa, India, Korea, China, Dubai, the UK, Germany, Singapore, Malaysia, Mauritius, Spain, and Egypt etc. Dr Ashleys Limited is also into pharmaceutical APIs. Since last 4 years, the company has made strong presence in the herbal, neutraceutical & food supplements. Dr Ashleys Limited is the fastest growing young research driven healthcare firm in incorporated in April 2012 in Hong Kong.

Dr Kannan Vishwanatth who is also a top academic researcher at the Garwood Innovation Fellow at Garwood Centre of Open Innovation, Haas School of Business Berkeley University of California said The global Pharma market size was valued at USD 484000.0 million in 2021 and is expected to expand at a CAGR of 11.8% during the forecast period, reaching USD 945000.0 million by 2027. The European Commission is pointing to the sharp increase in demand & despite the challenges & reforms, Europe will be a very key market.

Announcing the global initiatives of Dr Ashleys Limited for the pharmaceutical warehousing at Riga, Latvia, Dr. Kannan Vishwanatth, founder & managing director of Dr Ashleys Limited said Dr Ashleys Limited has passed the board resolution & its intent to start the mega pharma warehouse with a total area of 60,000 square feet & will be equipped with a robust warehouse management system operated by tailor-made designed easy to operate software, whose task is to monitor and streamline all internal processes carried out. The facility will have appropriate storage conditions & different drugs can have vastly different requirements in terms of temperature, humidity, and lighting. Dr Ashleys Limited's objective is to ensure that the storage of each drug is in line with its specific requirements defined by the manufacturer.

This can involve temperature-controlled warehousing and/or climate-controlled warehousing space both of which require state-of-the-art control and monitoring equipment to keep the space within specific environmental parameters. The key focus will be managing incoming goods, either from manufacturing or outside sources, effective organization and management of stock, control of the warehouse exit points, grouping the output commands based on its destination. Dr Ashleys Limited is clearly on the technological forefront with a fully-automated clad-rack warehouse It consists of two double-depth storage aisles and a conveyor circuit for inflowing and outflowing goods. The entire operation is controlled and managed by the warehouse management software.

To enrich growth and prosperity amongst Dr Ashleys Limited customers along with the business success. Dr Ashleys Limited defines new markets by continually extending the frontiers of research and development in its chosen field of business.

Nick Shwaney
Dr Ashley's Limited
+852 3421 1040
email us here
Visit us on social media:

Continue read on einpresswire.com

Logo GlobeNewswire
SciencePress Release2023-01-24 06:00:00
Exclusive licensing and distribution agreement signed with Salus Pharmaceuticals in Lithuania, Estonia, Latvia, Croatia, Slovenia, Serbia, North Macedonia,...

Logo EIN Presswire
HealthPress Release2023-01-23 21:16:52
ScanLeafs market penetration, along with additional licensing, further strengthens Valcons position in the European Medical Cannabis market. COPENHAGEN,...

Logo EIN Presswire
HealthPress Release2023-01-24 14:43:13
Emergen Research Logo Increase in the number of biopharmaceutical companies across the nations driving the growth of next-generation biomanufacturing in...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 17:29:00
Multi-hyphenate Kenji Saito, M.D., J.D. has agreed to join the Medical Advisory Board of Harvard MedTech, announced Gerry Stanley, M.D., Chief Medical...

Logo GlobeNewswire
SciencePress Release2023-01-24 08:00:00
Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core European markets LUGANO, Switzerland and...

Logo EIN Presswire
HealthPress Release2023-01-24 09:48:13
Digital Medicines Market Trends Digital medicine technology is an innovative technology that bridged the gap between healthcare and digital technology....

Logo EIN Presswire
HealthPress Release2023-01-24 14:04:31
Emergen Research Logo Increasing number of cancer cases, rising government initiatives and projects, new drug developments, and increasing demand for...

Logo PR Newswire
HealthPress Release2023-01-23 20:00:00
WOONSOCKET, R.I., Jan. 23, 2023 /PRNewswire/ -- CVS Health® (NYSE: CVS ) today announced two executive appointments. David Joyner will rejoin the company as...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 10:00:00
Gandeeva Therapeutics, Inc., a biotechnology company focused on designing and developing precision therapeutics guided by cryogenic electron microscopy...

Logo PR Newswire
HealthPress Release2023-01-24 14:00:00
BOSTON, Jan. 24, 2023 /PRNewswire/ -- Syner-G BioPharma Group ("Syner-G" or the "Company"), a leading provider of integrated pharmaceutical science and...

Logo GlobeNewswire
SciencePress Release2023-01-24 14:20:00
Immediately Accretive Addition to the Hemp/Cannabis Business with Positive EBITDA 1,276 Novel Food Applications for Cannabinoid Products to Accelerate Growth...

Logo GlobeNewswire
SciencePress Release2023-01-24 11:00:00
VANCOUVER, British Columbia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0), an autologous stem cell therapy company,...

Logo GlobeNewswire
EconomyPress Release2023-01-24 15:00:00
Burlingame, Jan. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Pharmaceutical Analytical Testing Market is estimated to be...

Logo PR Newswire
HealthPress Release2023-01-24 08:00:00
Belgium team to expand under Country Manager, Dr Pierre-Hervé Brun, providing CNS treatments to patients BRUSSELS and DÜSSELDORF, Germany, Jan. 24, 2023...

Logo PR Newswire
HealthPress Release2023-01-24 11:30:00
Expansion of manufacturing facility in North Carolina will increase the number of patients who may benefit from the company's medicines INDIANAPOLIS, Jan....

Logo GlobeNewswire
The global genitourinary drugs market size was valued at USD 32 billion in 2021 and is expected to surpass USD 68.51 billion by 2030, registering a CAGR of...

Logo GlobeNewswire
SciencePress Release2023-01-24 13:00:00
BOSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous system (CNS)...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 14:45:00
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the launch of its new Case...

Logo PR Newswire
HealthPress Release2023-01-24 12:05:00
Lindberg Brings Decades of Experience Driving Global Brand Growth to Leading Global Nutritional Products Provider SAN FRANCISCO, Jan. 24, 2023 /PRNewswire/...

Logo PR Newswire
HealthPress Release2023-01-24 13:44:00
CAMPBELL, Calif., Jan. 24, 2023 /PRNewswire/ -- List Labs, a live biotherapeutics-focused contract development manufacturing organization ( CDMO ), adds 500L...